We Know Drug Delivery
on drug delivery logo

check it out in this smart online viewer! -->

Issue N°63, January 2016

Ophthalmic Drug Delivery

DOWNLOAD COMPLETE ISSUE: LO RES PDF

DOWNLOAD COMPLETE ISSUE: HI RES PDF

CONTENTS:

Expert Overview: Development of Sustained-Release Ocular Delivery Technologies
Michael O'Rourke, President and Founder
Scotia Vision Consultants

ARTICLE PDF

Using Intelligent Design to Deliver Safe Preservative-Free Multi-Does Eye Drops
Fanny Sellier, Global Category Manager, Ophthalmic
Nemera

ARTICLE PDF

Introducing Ocusurf Nanostructured Emulsion as a 505(B)(2) Strategy
Shikha P Barman, Chief Executive Officer, Chief Technology Officer
Integral BioSystems

ARTICLE PDF

Improving Ophthalmic Drug Delivery With Novel Emulsion Technologies for Sterile Ustained-Release Injectables
Robin de Bruijn, Chief Technology Officer and Frank de Jong, Chief Executive Officer
EmulTech

ARTICLE PDF

A Topical Ocular Ring Designed to Replace Glaucoma Eye Drops
Anne Brody Rubin, Vice-President, Marketing
ForSight VISION5

ARTICLE PDF

Scalability of Micro Intraocular Implants and Devices
Donna Bibber, Chief Executive Officer
Micro Engineering Solutions

ARTICLE PDF

Drop-Less Therapy: A Reality
Chris Muller, Chief Commercial Officer and Deepank Utkhede, Chief Scientific Officer
Mati Therapeutics

ARTICLE PDF

New Solutions for Ophthalmic Drug Delivery Using Biodegradable Silica Matrix
Mika Jokinen, Research Director
Lasse Leino, President and Chief Executive Officer
Cora Griffin, Business Development Director
DelSiTech

ARTICLE PDF

Opsisporin: A Long-Acting Drug Delivery Approach for Uvetitis
Paul Seaman, Head of Sustained Delivery and Daniel Palmer, Chief Scientific Officer
Midatech Pharma

ARTICLE PDF

DOWNLOAD COMPLETE ISSUE: LO RES PDF

DOWNLOAD COMPLETE ISSUE: HI RES PDF

Capsugel

click through to website